ENvue Medical, Inc. (FEED)
NASDAQ: FEED · Real-Time Price · USD
0.3445
-0.0234 (-6.36%)
At close: Aug 28, 2026, 4:00 PM EDT
0.3600
+0.0155 (4.50%)
After-hours: Aug 28, 2026, 7:58 PM EDT
ENvue Medical Revenue
ENvue Medical had revenue of $239.00K in the quarter ending June 30, 2026, a decrease of -51.62%. This brings the company's revenue in the last twelve months to $1.93M, down -17.66% year-over-year. In the year 2025, ENvue Medical had annual revenue of $2.55M, down -0.20%.
Revenue (ttm)
$1.93M
Revenue Growth
-17.66%
P/S Ratio
1.98
Revenue / Employee
$137,571
Employees
14
Market Cap
3.82M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.55M | -5.00K | -0.20% |
| Dec 31, 2024 | 2.56M | 275.00K | 12.05% |
| Dec 31, 2023 | 2.28M | 1.53M | 203.59% |
| Dec 31, 2022 | 752.00K | -943.00K | -55.63% |
| Dec 31, 2021 | 1.70M | 1.07M | 172.07% |
| Dec 31, 2020 | 623.00K | 93.00K | 17.55% |
| Dec 31, 2019 | 530.00K | 212.00K | 66.67% |
| Dec 31, 2018 | 318.00K | 79.00K | 33.05% |
| Dec 31, 2017 | 239.00K | 10.00K | 4.37% |
| Dec 31, 2016 | 229.00K | 82.00K | 55.78% |
| Dec 31, 2015 | 147.00K | -56.00K | -27.59% |
| Dec 31, 2014 | 203.00K | -8.00K | -3.79% |
| Dec 31, 2013 | 211.00K | 45.00K | 27.11% |
| Dec 31, 2012 | 166.00K | 72.00K | 76.60% |
| Dec 31, 2011 | 94.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vivos Therapeutics | 20.90M |
| WORK Medical Technology Group LTD | 10.72M |
| Nuwellis | 9.01M |
| Beyond Air | 7.69M |
| Tenon Medical | 5.31M |
| Biomerica | 4.33M |
| Catheter Precision | 1.92M |
| Nexalin Technology | 217.16K |
FEED News
- 1 day ago - ENvue Medical announces 1-for-12 reverse stock split - TheFly
- 11 days ago - ENvue Medical enters exclusive distribution agreement with Peak Medical - TheFly
- 11 days ago - ENvue Medical Announces Exclusive UroShield® Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 Million - GlobeNewsWire
- 17 days ago - ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions - GlobeNewsWire
- 19 days ago - ENvue Medical files $50M mixed securities shelf - TheFly
- 25 days ago - ENvue Medical transitions NanoVibronix manufacturing operations to the U.S. - TheFly
- 25 days ago - ENvue Medical Moves NanoVibronix Manufacturing to the United States, Consolidates R&D in Tel Aviv, Israel, Increasing Operational Efficiencies and Cost Reduction Opportunities - GlobeNewsWire
- 5 weeks ago - ENvue Medical Deploys Additional Navigation Platform with Existing Customer, A Leading North Texas Medical Center - GlobeNewsWire